Drug
Fenfluramine clinical trials
Also written Fintepla and ZX008.
- studies test it
- 20
- open now
- 5
- in phase 3
- 10
- first study started
- 2016
Keep track of what changes. Save the Fenfluramine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Studies by the year they started
19 studies that test it; most in 2016 (3)
| Year | Studies |
|---|---|
| 2016 | 3 |
| 2017 | 2 |
| 2019 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 10
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 11
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (4) · UCB BIOSCIENCES, Inc. (3) · Zogenix, Inc. (2) · KU Leuven (1) · Hospital Ruber Internacional (1) · Elizabeth Anne Thiele (1) · NYU Langone Health (1) · University of Oxford (1)
Studies
Open first, then newest update. How each study uses Fenfluramine is read from its arms, and is right about nine times in ten.
Testing it · 20
- A Phase 3 Study of Fenfluramine Hydrochloride in Rett SyndromeRecruitingPhase 3UCB BIOSCIENCES, Inc.NCT07503444Written as fenfluramine hydrochloride
- The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome ProjectRecruitingPhase 4The University of Texas Health Science Center, HoustonNCT07112365Written as Fenfluramine treatment (Fintepla)
- Using Fenfluramine to Test the Serotonin Deficiency Theory of DepressionNot yet recruitingNot applicableImperial College Healthcare NHS TrustNCT07651293Written as Fenfluramine Hydrochloride
- Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of AgeRecruitingPhase 4University of Colorado, DenverNCT06598449Written as fenfluramine
- Treatment of Refractory Infantile Spasms With FenfluramineRecruitingPhase 2Children's Hospital of Orange CountyNCT04289467Written as Fenfluramine
- Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut EpilepsyCompletedPhase 2KU LeuvenNCT02655198Written as Fenfluramine
- Fenfluramine for the Treatment of Different Types of Developmental and Epileptic Encephalopathies: a Pilot Trial Exploring Epileptic and Non-epileptic OutcomesCompletedPhase 4Hospital Ruber InternacionalNCT05232630Written as Fenfluramine
- A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet SyndromeCompletedPhase 3UCB BIOSCIENCES, Inc.NCT06118255Written as fenfluramine
- A Study to Assess Drug-drug Interaction of ZX008 in Healthy Male and Female Study ParticipantsCompletedPhase 1UCB BIOSCIENCES, Inc.NCT06679413Written as fenfluramine HCl
- Fenfluramine for Adult Dravet PatientsTerminatedPhase 3University Health Network, TorontoNCT05560282Written as Fenfluramine
- A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder.Active, not recruitingPhase 3Zogenix, Inc.NCT05064878Written as Fenfluramine
- A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut SyndromeCompletedPhase 3Zogenix, Inc.NCT03936777Written as ZX008 (Fenfluramine Hydrochloride)
- An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT02823145Written as ZX008 (Fenfluramine Hydrochloride)
- Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25).CompletedPhase 3Elizabeth Anne ThieleNCT03790137Written as Fenfluramine Hydrochloride
- A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet SyndromeTerminatedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT03299842Written as ZX008 (Fenfluramine Hydrochloride)
- Fenfluramine in CDKL5 Deficiency Disorder (CDD)CompletedPhase 2NYU Langone HealthNCT03861871Written as Fenfluramine Hydrochloride
- A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT02682927Written as ZX008 (Fenfluramine Hydrochloride)
- Fenfluramine and CognitionCompletedPhase 4University of OxfordNCT05026398Written as Fenfluramine
- A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet SyndromeCompletedPhase 3Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.NCT02926898Written as ZX008 (Fenfluramine Hydrochloride)
- Predictive Values of Serotonergic Alterations for Outcome - 2TerminatedPhase 1National Institute on Drug Abuse (NIDA)NCT00000313Written as Fenfluramine
Codes
What other systems call Fenfluramine · ClinicalTrials.gg INT007480
- MeSH (NLM) D005277FenfluramineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 2DS058H2CFFENFLURAMINEConfirmed FDA, NLM, Wikidata
- RxNorm 4328Confirmed FDA, Wikidata
- Wikidata Q418928(RS)-fenfluramineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81418FenfluramineOne source FDA
- DrugBank DB00574One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005277 | Fenfluramine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 2DS058H2CF | FENFLURAMINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 4328 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418928 | (RS)-fenfluramine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81418 | Fenfluramine | One source FDA |
| DrugBank | DB00574 | — | One source Wikidata |
Also registered as fenfluramine hydrochloride (UNII 3KC089243P · RxNorm 82018).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.